Epizyme
Epizyme is a Massachusetts-based biopharmaceutical company that develops and commercializes novel epigenetic medicines for the treatment of cancer.
Business Model:
Revenue: $53M
Employees: 201-500
Industries / Tags:
Detailed Epizyme Information
Geographic Data
Address: 400 Technology Square
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$0
Raised Total:$834M
Social
Metrics
677,158Website Global Rank
60,819Website Monthly Traffic
Twitter Followers
Description
Epizyme is a Massachusetts-based biopharmaceutical company that develops and commercializes novel epigenetic medicines for the treatment of cancer.
Contact Phone:
+16172295872
Contact Email:
Epizyme went public on 5/31/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/31/2013
IPO Valuation:
$400M
Ticker Symbol:
EPZM
IPO Price:
$15/share
Amount Raised:
$77M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
